FinBoss.io
CSEN
  • Crypto prices
  • Liquidation War
  • Crypto tools
  • Bitcoin on-chain
  • US macro
  • US stocks
    • Largest US stocks
    • Stock screener
    • Earnings calendar
    • Insider trading
    • Market heatmap
  • Markets
  • Tools
  • Guides
  • FinBot
FinBoss.io
Crypto prices
Liquidation War
Crypto tools
Altcoin Season Index
Big players (on-chain)
Bitcoin halving countdown
Bear market radar
Bitcoin on-chain
Hashrate
Mining difficulty
Mining pools
Mempool and fees
On-chain activity
MVRV and NUPL
SOPR
Holders
Supply in profit
Rainbow Chart
Fair value
Pi Cycle Top
US macro
FedWatch
Interest rates
Treasury yields
Inflation
Liquidity and Bitcoin
Business cycle
US stocks
Largest US stocks
Stock screener
Earnings calendar
Insider trading
Market heatmap
Markets
Stock indices
Commodities
Forex rates
Bear market radar
Famous investors' portfolios
Tools
Dashboards
Investor dashboardTrader dashboardBeginner dashboard
Calculators
Compound interestDCA calculatorDrawdown recovery
Compare
BrokersCrypto exchanges
Přehled sekce Tools →
Guides
FinBot
CSEN
Home
Stocks
Charles RIV Labs Intl Inc
CR

Charles RIV Labs Intl Inc

CRLNASDAQ

Stock · Data from SEC EDGAR 13F · Held by 10 of 87 tracked investors

$358.84
▲ 0.44%
Famous investorshold 10buying 0selling 0
Price (USD)
$358.84
Market cap
$17.3B
P/E ratio
–
Tracked investors holding
10 of 87
Next earnings
4 Nov 2026

Charles RIV Labs Intl Inc at a glance

An overview of the financial statements, in plain language. Switch to the advanced view for charts.

FinBoss score
47out of 100
  • Valuation52
  • Growth31
  • Profitability41
  • Quality46
  • Debt45
  • Stability69
In its favour
  • Nothing notable from the statements.
What to watch
  • !The company is loss-making: net profit is negative.
  • !Net debt is high: at the current free cash flow it would take 6.1 years to repay.
  • !Revenue grew only 0.3% a year over 3 years.
  • !The analysts' average target is 11% below the price.

The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.

Is the stock expensive?

Reasonably priced

The company has no earnings, so the P/E cannot be calculated.

P/E
–
P/S
4.3×
EV/EBITDA
23.6×

Is the company growing?

Flat
22
23
24
25

Revenue over 3 years grew 0.3% a year. Last year -2.7%.

Does it make money?

Loss-making
  • Cost of sales 67

Revenue and net profit (USD B)

Margins (% of revenue)

Free cash flow and capex (USD B)

Cash and debt (USD B)

Earnings per share (EPS, USD)

Latest quarters (USD B)

Earnings results

QuarterReportedEPSAnalyst estimateSurprise
Jun 20265 Aug 20263.022.72+11%
Mar 20267 May 20262.061.96+5.1%
Dec 202518 Feb 20262.392.33+2.6%
Sep 20255 Nov 20252.432.32+4.7%

EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.

Chart CRL

Insider purchases

last 90 days, SEC Form 4
Loading insider trades…

Which investors hold this stock

10
JR
John Rogers
Ariel Investments
3.41%$341,587,697▲ +4.3%
BN
Bill Nygren
Oakmark (Harris Associates)
0.67%$508,269,048▲ +4.1%
JG
Joel Greenblatt
Gotham Asset Management
0.23%$98,233,181▲ +20.8%
IE
Israel Englander
Millennium Management
0.04%$110,324,717▼ -47.9%
KG
Ken Griffin
Citadel Advisors
0.03%$270,696,771▼ -1.5%
Čn
Česká národní banka
Česká národní banka
0.02%$4,046,652unchanged
LB
Louis Bacon
Moore Capital Management
0.01%$882,667▼ -91%
Ns
Norský státní fond
Norges Bank
0.01%$83,921,372New position
Šn
Švýcarská národní banka
Swiss National Bank
0.01%$22,452,210▲ +1.7%
KF
Ken Fisher
Fisher Investments
0%$227,394New position

Frequently asked questions

How much is Charles RIV Labs Intl Inc (CRL) stock?

Charles RIV Labs Intl Inc shares trade at $358.84, +0.44% over the last trading day. The price is delayed.

What is the market cap of Charles RIV Labs Intl Inc?

The market cap of Charles RIV Labs Intl Inc is about $17.3B.

Which big investors hold Charles RIV Labs Intl Inc?

According to the latest 13F filings, 10 of 87 tracked investors hold Charles RIV Labs Intl Inc, for example John Rogers, Bill Nygren, Joel Greenblatt.

When will Charles RIV Labs Intl Inc report its next results?

The next earnings report of Charles RIV Labs Intl Inc is expected on 4 Nov 2026.

Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.

© 2026 FinBoss.io. All rights reserved.

How we make moneyTerms of usePrivacy policyCookie policy

Disclaimer: the information on this site is for general information only and is not investment or financial advice. Investing involves risk, and cryptocurrencies are especially volatile. Past performance does not guarantee future results. Some links are affiliate links and are marked as ads.

  • Research 0.0
  • Operations and selling 23.0
  • Taxes and other 13.6
  • Net profit -3.6
  • Out of 100 USD of revenue, -3.6 USD is left as net profit.

    Is it financially healthy?

    Mostly
    Cash
    192M USD
    Debt
    3.0B USD
    Free CF
    469M USD

    It could repay its net debt from free cash flow in 6.1 years.

    Does it pay a dividend?

    No dividend

    The company pays no dividend. It reinvests the money or holds it.

    What do analysts expect?

    Buy
    Average target
    318.87 USD
    Vs price
    −11%

    15 analysts. Their opinion is not a recommendation by FinBoss.io.

    Which big investors hold it?

    10 of 87

    Among the tracked investors, John Rogers, Bill Nygren, Joel Greenblatt and others hold the stock according to 13F filings.

    Ratios

    P/E
    –
    Forward P/E
    28.2×
    P/B
    6.0×
    P/S
    4.3×
    PEG
    0.12
    EV/EBITDA
    23.6×
    Gross margin
    34.6%
    Operating margin
    15.1%
    Net margin
    -6.0%
    ROE
    -7.5%
    ROA
    4.1%
    Debt / equity
    1.1×
    Current ratio
    1.3×
    Revenue growth
    -2.7%
    Earnings growth
    –
    Beta
    1.40
    Dividend
    0.00%
    Payout ratio
    0%